Emerging Pathogen Threats in Transfusion Medicine: Improving Safety and Confidence with Pathogen Reduction Technologies
Pathogens · 05.07.2023 · 12 (7) · 911
DOI: 10.3390/pathogens12070911 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 05.07.2023. Verfasst von Marcia Cardoso und 3 weiteren Autor:innen. Beteiligte Einrichtung: Terumo BCT, Inc., TERUMO Böood and Cell Technologies, Zaventem, 41 1930 Brussels, Belgium. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Emerging infectious disease threats are becoming more frequent due to various social, political, and geographical pressures, including increased human–animal contact, global trade, transportation, and changing climate conditions. Since blood products for transfusion are derived from donated blood from the general population, emerging agents spread by blood contact or the transfusion of blood products are also a potential risk. Blood transfusions are essential in treating patients with anemia, blood loss, and other medical conditions. However, these lifesaving procedures can contribute to infectious disease transmission, particularly to vulnerable populations. New methods have been implemented on a global basis for the prevention of transfusion transmissions via plasma, platelets, and whole blood products. Implementing proactive pathogen reduction methods may reduce the likelihood of disease transmission via blood transfusions, even for newly emerging agents whose transmissibility and susceptibility are still being evaluated as they emerge. In this review, we consider the Mirasol PRT system for blood safety, which is based on a photochemical method involving riboflavin and UV light. We provide examples of how emerging threats, such as Ebola, SARS-CoV-2, hepatitis E, mpox and other agents, have been evaluated in real time regarding effectiveness of this method in reducing the likelihood of disease transmission via transfusions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Terumo BCT, Inc., TERUMO Böood and Cell Technologies, Zaventem, 41 1930 Brussels, Belgium.
- Infectious Disease Research Center, Department of Biomedical Science, Colorado State University, Fort Collins, CO 80521, USA.
- Infectious Disease Research Center, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80521, USA.
ORCID-Profile: Marcia Cardoso, Izabela Ragan, Lindsay Hartson, Raymond P Goodrich
Zitieren
APA
Cardoso, M., Ragan, I., Hartson, L., & Goodrich, R. P. (2023). Emerging Pathogen Threats in Transfusion Medicine: Improving Safety and Confidence with Pathogen Reduction Technologies. Pathogens, 12(7), 911. https://doi.org/10.3390/pathogens12070911
Vancouver
Cardoso M, Ragan I, Hartson L, Goodrich RP. Emerging Pathogen Threats in Transfusion Medicine: Improving Safety and Confidence with Pathogen Reduction Technologies. Pathogens. 2023;12(7):911. doi:10.3390/pathogens12070911
BibTeX
@article{Cardoso2023,
author = {Cardoso, Marcia and Ragan, Izabela and Hartson, Lindsay and Goodrich, Raymond P},
title = {Emerging Pathogen Threats in Transfusion Medicine: Improving Safety and Confidence with Pathogen Reduction Technologies},
journal = {Pathogens},
year = {2023},
volume = {12},
number = {7},
pages = {911},
doi = {10.3390/pathogens12070911}
}
EUVIMED